Condensed Consolidated Balance Sheets - USD ($)		Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents		$ 9,412,539	$ 8,446,158
Unbilled revenue			171,254
Research and development incentives receivable, current			23,894
Deferred issuance cost		5,861
Prepaid expenses and other current assets		244,472	866,014
Total current assets		9,662,872	9,507,320
Security deposit		22,777	22,777
Office furniture and equipment, net		8,751	11,927
Right-of-use lease assets		170,679	229,834
Research and development incentives receivable, net of current portion			25,468
Total assets		9,865,079	9,797,326
Current liabilities:
Accounts payable		1,698,225	1,111,226
Accrued expenses		1,701,806	2,418,002
Accrued compensation		80,244	251,115
Lease liabilities, current		128,592	121,765
Convertible debt		2,745,745	2,250,000
Total current liabilities		6,354,612	6,152,108
Non-current liabilities:
Convertible debt			1,010,934
Lease liabilities, net of current portion		45,691	111,862
Total liabilities		6,400,303	7,274,904
Commitments and contingencies (Note 6)
Shareholders' equity:
Preferred stock, 350,000 shares authorized; none issued or outstanding at June 30, 2024 and December 31, 2023, respectively		0	0
Common stock, $.001 par value; 75,000,000 shares authorized; 1,542,480 and 648,761 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	[1]	1,542	649
Additional paid-in capital (1)	[1]	232,699,640	228,203,706
Accumulated other comprehensive income		27,599	22,243
Accumulated deficit		(229,264,005)	(225,704,176)
Total shareholders' equity		3,464,776	2,522,422
Total liabilities and shareholders' equity		$ 9,865,079	$ 9,797,326

[1] Adjusted to reflect the reverse stock split of one-for-sixteen effective June 5, 2024